Dr. Cassandra Alayne Gandle, MD

Dr. Gandle practices at Wiregrass Ranch Ambulatory Surgery Center in Tampa, Florida.

Dr. Gandle's NPI, 1669908703, was assigned on May 11, 2017. Dr. Gandle graduated from Tulane School of Medicine in 2017. Dr. Gandle holds Florida license ME160721.

Dr. Gandle's primary practice is Wiregrass Ranch Ambulatory Surgery Center, at 14547 Bruce B Downs Blvd, Tampa, FL 33613. The practice phone is (813) 978-1494.

Dr. Gandle's primary practice is Wiregrass Ranch Ambulatory Surgery Center in Tampa, Florida. Dr. Gandle is also affiliated with AdventHealth Tampa. The medical group on file is Florida Medical Clinic Orlando Health. Dmand AI also links Dr. Gandle to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gandle practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gandle's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gandle is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Gandle is licensed in Florida.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy and irritable bowel syndrome (IBS) among the conditions Dr. Gandle treats.

CMS data shows 812 Medicare services from Dr. Gandle across 11 procedure codes in 2024, for 390 Medicare patients. Medicare paid $76,680 for them.

CMS counts 390 Medicare patients who saw Dr. Gandle in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gandle's median patient age at 62, with 77% women.

In 2024, Dr. Gandle wrote 1,005 Medicare Part D claims for 372 patients. 81% of them were for generic drugs. CMS names the drug for 883 of them, across 13 drugs with 11 or more claims each, at $93,983 in total drug cost. In 2023, CMS named 117 claims across 5 drugs.

Dr. Gandle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of colonoscopy by Dr. Gandle, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Gandle, published from 2018 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Inflammatory Bowel Diseases and Radiation Injuries. Dr. Gandle has published most often in Clin Gastroenterol Hepatol. Dr. Gandle's most frequent co-authors are Jason Ken Hou, MD, Suneal Kumar Agarwal, MD and Hashem Beshir El-Serag, MD, MPH.

CMS Open Payments shows 163 general payments to Dr. Gandle from 26 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,555.

Dmand AI lists 2 awards for Dr. Gandle, most recently Internal Medicine Clerkship Honors Award in 2016.

Dr. Gandle graduated from Tulane School of Medicine in 2017. Dr. Gandle is a member of ACG, American Gastroenterological Association and ASGE.

Dr. Gandle is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.